Patents by Inventor Emerson Quan

Emerson Quan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8007746
    Abstract: An M.times.N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: August 30, 2011
    Assignee: Fluidigm Corporation
    Inventors: Marc Unger, Jiang Huang, Emerson Quan
  • Patent number: 7867454
    Abstract: An M.times.N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: January 11, 2011
    Assignee: Fluidigm Corporation
    Inventors: Federico Goodsaid, Marc Unger, Jiang Huang, Emerson Quan
  • Publication number: 20090142236
    Abstract: An M.times.N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block.
    Type: Application
    Filed: October 30, 2007
    Publication date: June 4, 2009
    Applicant: Fluidigm Corporation
    Inventors: Marc Unger, Jiang Huang, Emerson Quan
  • Patent number: 7476363
    Abstract: An M×N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block.
    Type: Grant
    Filed: May 2, 2004
    Date of Patent: January 13, 2009
    Assignee: Fluidigm Corporation
    Inventors: Marc Unger, Jiang Huang, Emerson Quan
  • Publication number: 20080292504
    Abstract: An M.times.N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block.
    Type: Application
    Filed: October 30, 2007
    Publication date: November 27, 2008
    Applicant: Fluigm Corporation
    Inventors: Federico Goodsaid, Marc Unger, Jiang Huang, Emerson Quan
  • Publication number: 20050145496
    Abstract: An M×N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block.
    Type: Application
    Filed: June 23, 2004
    Publication date: July 7, 2005
    Inventors: Federico Goodsaid, Marc Unger, Jiang Huang, Emerson Quan
  • Publication number: 20050084421
    Abstract: An M×N matrix microfluidic device for performing a matrix of reactions, the device having a plurality of reaction cells in communication with one of either a sample inlet or a reagent inlet through a via formed within an elastomeric block of the device. Methods provided include a method for forming vias in parallel in an elastomeric layer of an elastomeric block of a microfluidic device, the method comprising using patterned photoresist masks and etching reagents to etch away regions or portions of an elastomeric layer of the elastomeric block.
    Type: Application
    Filed: May 2, 2004
    Publication date: April 21, 2005
    Applicant: Fluidigm Corporation
    Inventors: Marc Unger, Jiang Huang, Emerson Quan
  • Patent number: 6882880
    Abstract: The change in tissue impedance due to the change in the extracellular matrix that results from the degradation of cartilage is utilized to detect degradation of articular cartilage. A probe includes electrodes that apply a current to the articular cartilage which results in a current distribution and electric field within the cartilage, along with an associated voltage drop across the electrodes. The amplitude of this voltage drop is then measured and divided by the current applied to determine the tissue impedance. By measuring the impedance of patient tissue and comparing the detected patient impedance to a normal value for the tissue from clinically normal tissue, a determination of whether the patient tissue is degraded, and a determination of the extent of degradation is possible. Preferably, the impedance is measured using a probe with interdigitated electrodes.
    Type: Grant
    Filed: December 19, 2002
    Date of Patent: April 19, 2005
    Assignee: Massachusetts Institute of Technology
    Inventors: Steven Treppo, Alan J. Grodzinsky, Emerson Quan, Eliot Frank, David Bombard, David Breslau
  • Patent number: 6856834
    Abstract: The change in tissue impedance due to the change in the extracellular matrix that results from the degradation of cartilage is utilized to detect degradation of articular cartilage. A probe comprising electrodes is applies a current to the articular cartilage which results in a current distribution and electric field within the cartilage, along with an associated voltage drop across the electrodes. The amplitude of this voltage drop is then measured and divided by the current applied to determine the tissue impedance. By measuring the impedance of patient tissue and comparing the detected patient impedance to a normal value for the tissue from clinically normal tissue, a determination of whether the patient tissue is degraded and the extent of degradation is possible. Preferably, the impedance is measured using a probe with interdigitated electrodes. By changing which electrodes are utilized, the wavelength of the current distribution changes, allowing the probe to image depth dependent focal lesions.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: February 15, 2005
    Assignee: Massachusetts Institute of Technology
    Inventors: Steven Treppo, Alan J. Grodzinsky, Emerson Quan, Eliot Frank, David Bombard, David Breslau
  • Patent number: 6735468
    Abstract: The change in tissue impedance due to the change in the extracellular matrix that results from the degradation of cartilage is utilized to detect degradation of articular cartilage. A probe applies a current to the articular cartilage which results in a current distribution and electric field within the cartilage, along with an associated voltage drop across the electrodes. The amplitude of this voltage drop is then measured and divided by the current applied to determine the tissue impedance. By measuring the impedance of patient tissue and comparing the detected patient impedance to a normal value for the tissue from clinically normal tissue, a determination of whether the patient tissue is degraded and the extent of degradation is possible. Preferably, the impedance is measured using a probe with interdigitated electrodes. By changing which electrodes are utilized, the wavelength of the current distribution changes, allowing the probe to image depth dependent focal lesions.
    Type: Grant
    Filed: February 2, 2001
    Date of Patent: May 11, 2004
    Assignee: Massachusetts Institute of Technology
    Inventors: Steven Treppo, Alan J. Grodzinsky, Emerson Quan, Eliot Frank, David Bombard, David Breslau
  • Publication number: 20040087869
    Abstract: The change in tissue impedance due to the change in the extracellular matrix that results from the degradation of cartilage is utilized to detect degradation of articular cartilage. A probe comprising electrodes is applies a current to the articular cartilage which results in a current distribution and electric field within the cartilage, along with an associated voltage drop across the electrodes. The amplitude of this voltage drop is then measured and divided by the current applied to determine the tissue impedance. By measuring the impedance of patient tissue and comparing the detected patient impedance to a normal value for the tissue from clinically normal tissue, a determination of whether the patient tissue is degraded and the extent of degradation is possible. Preferably, the impedance is measured using a probe with interdigitated electrodes. By changing which electrodes are utilized, the wavelength of the current distribution changes, allowing the probe to image depth dependent focal lesions.
    Type: Application
    Filed: June 20, 2003
    Publication date: May 6, 2004
    Inventors: Steven Treppo, Alan J. Grodzinsky, Emerson Quan, Eliot Frank, David Bombard, David Breslau
  • Publication number: 20030149376
    Abstract: The change in tissue impedance due to the change in the extracellular matrix that results from the degradation of cartilage is utilized to detect degradation of articular cartilage. A probe comprising electrodes is applies a current to the articular cartilage which results in a current distribution and electric field within the cartilage, along with an associated voltage drop across the electrodes. The amplitude of this voltage drop is then measured and divided by the current applied to determine the tissue impedance. By measuring the impedance of patient tissue and comparing the detected patient impedance to a normal value for the tissue from clinically normal tissue, a determination of whether the patient tissue is degraded and the extent of degradation is possible. Preferably, the impedance is measured using a probe with interdigitated electrodes. By changing which electrodes are utilized, the wavelength of the current distribution changes, allowing the probe to image depth dependent focal lesions.
    Type: Application
    Filed: December 19, 2002
    Publication date: August 7, 2003
    Inventors: Steven Treppo, Alan J. Grodzinsky, Emerson Quan, Eliot Frank, David Bombard, David Breslau
  • Publication number: 20020045838
    Abstract: The change in tissue impedance due to the change in the extracellular matrix that results from the degradation of cartilage is utilized to detect degradation of articular cartilage. A probe comprising electrodes is applies a current to the articular cartilage which results in a current distribution and electric field within the cartilage, along with an associated voltage drop across the electrodes. The amplitude of this voltage drop is then measured and divided by the current applied to determine the tissue impedance. By measuring the impedance of patient tissue and comparing the detected patient impedance to a normal value for the tissue from clinically normal tissue, a determination of whether the patient tissue is degraded and the extent of degradation is possible. Preferably, the impedance is measured using a probe with interdigitated electrodes. By changing which electrodes are utilized, the wavelength of the current distribution changes, allowing the probe to image depth dependent focal lesions.
    Type: Application
    Filed: February 2, 2001
    Publication date: April 18, 2002
    Inventors: Steven Treppo, Alan J. Grodzinsky, Emerson Quan, Eliot Frank, David Bombard, David Breslau